Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 84

1.

Inference of transcription factor binding from cell-free DNA enables tumor subtype prediction and early detection.

Ulz P, Perakis S, Zhou Q, Moser T, Belic J, Lazzeri I, Wölfler A, Zebisch A, Gerger A, Pristauz G, Petru E, White B, Roberts CES, John JS, Schimek MG, Geigl JB, Bauernhofer T, Sill H, Bock C, Heitzer E, Speicher MR.

Nat Commun. 2019 Oct 11;10(1):4666. doi: 10.1038/s41467-019-12714-4.

2.

Age as a Predictor of Treatment Outcome in Metastatic Testicular Germ Cell Tumors.

Terbuch A, Posch F, Bauernhofer T, Pichler M, Peinsith H, Szkandera J, Riedl J, Hutterer GC, Pummer K, Partl R, Kapp KS, Stöger H, Stotz M, Gerger A.

Anticancer Res. 2019 Oct;39(10):5589-5596. doi: 10.21873/anticanres.13753.

PMID:
31570454
3.

Real-World Evidence Data on Metastatic Renal-Cell Carcinoma Treatment in Austria: The RELACS Study.

Schmidinger M, Pichler R, Loidl W, Bauernhofer T, Kretz M, Tinchon C, Niedersüß-Beke D, Pfleger G, Wiesinger CG, Vogl U, Mitterberger M, Stöger H, Tulchiner G, Kratochvill F, Gerritsmann H, Mraz B, Marszalek M.

Clin Genitourin Cancer. 2019 Oct;17(5):e957-e967. doi: 10.1016/j.clgc.2019.05.017. Epub 2019 May 25.

4.

Stromal coexpression of uPA/PAI-1 protein predicts poor disease outcome in endocrine-treated postmenopausal patients with receptor-positive early breast cancer.

Singer CF, Filipits M, Jahn SW, Abete L, Jakesz R, Greil R, Bauernhofer T, Kwasny W, Seifert M, Fitzal F, Kastner M, Schmitt M, Moinfar F, Gnant M.

Breast. 2019 Aug;46:101-107. doi: 10.1016/j.breast.2019.05.007. Epub 2019 May 3.

PMID:
31132475
5.

Benefit of second-line systemic chemotherapy for advanced biliary tract cancer: A propensity score analysis.

Moik F, Riedl JM, Winder T, Terbuch A, Rossmann CH, Szkandera J, Bauernhofer T, Kasparek AK, Schaberl-Moser R, Reicher A, Prinz F, Pichler M, Stöger H, Stotz M, Gerger A, Posch F.

Sci Rep. 2019 Apr 3;9(1):5548. doi: 10.1038/s41598-019-42069-1.

6.

Volume Computed Tomography Perfusion Imaging: Evaluation of the Significance in Oncologic Follow-up of Metastasizing Renal Cell Carcinoma in the Early Period of Targeted Therapy - Preliminary Results.

Vehabovic-Delic A, Balic M, Rossmann C, Bauernhofer T, Deutschmann HA, Schoellnast H.

J Comput Assist Tomogr. 2019 May/Jun;43(3):493-498. doi: 10.1097/RCT.0000000000000848.

PMID:
30762651
7.

MiR-1287-5p inhibits triple negative breast cancer growth by interaction with phosphoinositide 3-kinase CB, thereby sensitizing cells for PI3Kinase inhibitors.

Schwarzenbacher D, Klec C, Pasculli B, Cerk S, Rinner B, Karbiener M, Ivan C, Barbano R, Ling H, Wulf-Goldenberg A, Stanzer S, Rinnerthaler G, Stoeger H, Bauernhofer T, Haybaeck J, Hoefler G, Jahn SW, Parrella P, Calin GA, Pichler M.

Breast Cancer Res. 2019 Feb 1;21(1):20. doi: 10.1186/s13058-019-1104-5.

8.

A Pilot Randomized Trial Assessing the Effect of a Psychoeducational Intervention on Psychoneuroimmunological Parameters Among Patients With Nonmetastatic Breast Cancer.

Stanzer S, Andritsch E, Zloklikovits S, Ladinek V, Farkas C, Augustin T, Obermayer-Pietsch B, Samonigg H, Bauernhofer T.

Psychosom Med. 2019 Feb/Mar;81(2):165-175. doi: 10.1097/PSY.0000000000000656.

PMID:
30489436
9.

MiR-371a-3p Serum Levels Are Increased in Recurrence of Testicular Germ Cell Tumor Patients.

Terbuch A, Adiprasito JB, Stiegelbauer V, Seles M, Klec C, Pichler GP, Resel M, Posch F, Lembeck AL, Stöger H, Szkandera J, Pummer K, Bauernhofer T, Hutterer GC, Gerger A, Stotz M, Pichler M.

Int J Mol Sci. 2018 Oct 12;19(10). pii: E3130. doi: 10.3390/ijms19103130.

10.

Genomic alterations in plasma DNA from patients with metastasized prostate cancer receiving abiraterone or enzalutamide.

Belic J, Graf R, Bauernhofer T, Cherkas Y, Ulz P, Waldispuehl-Geigl J, Perakis S, Gormley M, Patel J, Li W, Geigl JB, Smirnov D, Heitzer E, Gross M, Speicher MR.

Int J Cancer. 2018 Sep 1;143(5):1236-1248. doi: 10.1002/ijc.31397. Epub 2018 Apr 10.

11.

Risk stratification for febrile neutropenia in patients with testicular germ cell tumors.

Terbuch A, Posch F, Partl R, Zurl B, Bauernhofer T, Pichler M, Szkandera J, Hutterer GC, Pummer K, Kapp KS, Stöger H, Gerger A, Stotz M.

Cancer Med. 2018 Feb;7(2):508-514. doi: 10.1002/cam4.1317. Epub 2018 Jan 19.

12.

In Situ Detection and Quantification of AR-V7, AR-FL, PSA, and KRAS Point Mutations in Circulating Tumor Cells.

El-Heliebi A, Hille C, Laxman N, Svedlund J, Haudum C, Ercan E, Kroneis T, Chen S, Smolle M, Rossmann C, Krzywkowski T, Ahlford A, Darai E, von Amsberg G, Alsdorf W, König F, Löhr M, de Kruijff I, Riethdorf S, Gorges TM, Pantel K, Bauernhofer T, Nilsson M, Sedlmayr P.

Clin Chem. 2018 Mar;64(3):536-546. doi: 10.1373/clinchem.2017.281295. Epub 2018 Jan 4.

13.

Long-term cardiovascular complications in stage I seminoma patients.

Terbuch A, Posch F, Annerer LM, Bauernhofer T, Pichler M, Szkandera J, Hutterer GC, Pummer K, Partl R, Kapp KS, Stöger H, Gerger A, Stotz M.

Clin Transl Oncol. 2017 Nov;19(11):1400-1408. doi: 10.1007/s12094-017-1742-y. Epub 2017 Aug 29.

14.

Biosimilars in the Treatment of Breast Cancer.

Balic M, Bartsch R, Bauernhofer T, Vrbanec D, Vrdoljak E.

Breast Care (Basel). 2017 Jul;12(3):192-194. doi: 10.1159/000477926. Epub 2017 Jun 13. No abstract available.

15.

Risk stratification for venous thromboembolism in patients with testicular germ cell tumors.

Bezan A, Posch F, Ploner F, Bauernhofer T, Pichler M, Szkandera J, Hutterer GC, Pummer K, Gary T, Samonigg H, Beyer J, Winder T, Hermanns T, Fankhauser CD, Gerger A, Stotz M.

PLoS One. 2017 Apr 21;12(4):e0176283. doi: 10.1371/journal.pone.0176283. eCollection 2017.

16.

Current Insights into Long Non-Coding RNAs (LncRNAs) in Prostate Cancer.

Smolle MA, Bauernhofer T, Pummer K, Calin GA, Pichler M.

Int J Mol Sci. 2017 Feb 22;18(2). pii: E473. doi: 10.3390/ijms18020473. Review.

17.

Comprehensive Analysis of miRNome Alterations in Response to Sorafenib Treatment in Colorectal Cancer Cells.

Pehserl AM, Ress AL, Stanzer S, Resel M, Karbiener M, Stadelmeyer E, Stiegelbauer V, Gerger A, Mayr C, Scheideler M, Hutterer GC, Bauernhofer T, Kiesslich T, Pichler M.

Int J Mol Sci. 2016 Dec 1;17(12). pii: E2011.

18.

KCNJ3 is a new independent prognostic marker for estrogen receptor positive breast cancer patients.

Kammerer S, Sokolowski A, Hackl H, Platzer D, Jahn SW, El-Heliebi A, Schwarzenbacher D, Stiegelbauer V, Pichler M, Rezania S, Fiegl H, Peintinger F, Regitnig P, Hoefler G, Schreibmayer W, Bauernhofer T.

Oncotarget. 2016 Dec 20;7(51):84705-84717. doi: 10.18632/oncotarget.13224.

19.

mFast-SeqS as a Monitoring and Pre-screening Tool for Tumor-Specific Aneuploidy in Plasma DNA.

Belic J, Koch M, Ulz P, Auer M, Gerhalter T, Mohan S, Fischereder K, Petru E, Bauernhofer T, Geigl JB, Speicher MR, Heitzer E.

Adv Exp Med Biol. 2016;924:147-155.

PMID:
27753036
20.

Critical evaluation of KCNJ3 gene product detection in human breast cancer: mRNA in situ hybridisation is superior to immunohistochemistry.

Kammerer S, Jahn SW, Winter E, Eidenhammer S, Rezania S, Regitnig P, Pichler M, Schreibmayer W, Bauernhofer T.

J Clin Pathol. 2016 Dec;69(12):1116-1121. doi: 10.1136/jclinpath-2016-203798. Epub 2016 Oct 3.

21.

Overexpression of KCNJ3 gene splice variants affects vital parameters of the malignant breast cancer cell line MCF-7 in an opposing manner.

Rezania S, Kammerer S, Li C, Steinecker-Frohnwieser B, Gorischek A, DeVaney TT, Verheyen S, Passegger CA, Tabrizi-Wizsy NG, Hackl H, Platzer D, Zarnani AH, Malle E, Jahn SW, Bauernhofer T, Schreibmayer W.

BMC Cancer. 2016 Aug 12;16:628. doi: 10.1186/s12885-016-2664-8.

22.

Whole-genome plasma sequencing reveals focal amplifications as a driving force in metastatic prostate cancer.

Ulz P, Belic J, Graf R, Auer M, Lafer I, Fischereder K, Webersinke G, Pummer K, Augustin H, Pichler M, Hoefler G, Bauernhofer T, Geigl JB, Heitzer E, Speicher MR.

Nat Commun. 2016 Jun 22;7:12008. doi: 10.1038/ncomms12008.

23.

Erratum to: Iron metabolism and iron supplementation in cancer patients.

Ludwig H, Evstatiev R, Kornek G, Aapro M, Bauernhofer T, Buxhofer-Ausch V, Fridrik M, Geissler D, Geissler K, Gisslinger H, Koller E, Kopetzky G, Lang A, Rumpold H, Steurer M, Kamali H, Link H.

Wien Klin Wochenschr. 2015 Dec;127(23-24):920-1. doi: 10.1007/s00508-015-0893-5. No abstract available.

24.

Iron metabolism and iron supplementation in cancer patients.

Ludwig H, Evstatiev R, Kornek G, Aapro M, Bauernhofer T, Buxhofer-Ausch V, Fridrik M, Geissler D, Geissler K, Gisslinger H, Koller E, Kopetzky G, Lang A, Rumpold H, Steurer M, Kamali H, Link H.

Wien Klin Wochenschr. 2015 Dec;127(23-24):907-19. doi: 10.1007/s00508-015-0842-3. Epub 2015 Sep 15. Review. Erratum in: Wien Klin Wochenschr. 2015 Dec;127(23-24):920-1.

25.

Rapid Identification of Plasma DNA Samples with Increased ctDNA Levels by a Modified FAST-SeqS Approach.

Belic J, Koch M, Ulz P, Auer M, Gerhalter T, Mohan S, Fischereder K, Petru E, Bauernhofer T, Geigl JB, Speicher MR, Heitzer E.

Clin Chem. 2015 Jun;61(6):838-49. doi: 10.1373/clinchem.2014.234286. Epub 2015 Apr 20.

26.

Piezo1 forms mechanosensitive ion channels in the human MCF-7 breast cancer cell line.

Li C, Rezania S, Kammerer S, Sokolowski A, Devaney T, Gorischek A, Jahn S, Hackl H, Groschner K, Windpassinger C, Malle E, Bauernhofer T, Schreibmayer W.

Sci Rep. 2015 Feb 10;5:8364. doi: 10.1038/srep08364.

27.

Complete recovery of a wide local reaction by the use of dexrazoxane 72 hours after epirubicin extravasation: case report and review of the literature.

Aigner B, Bauernhofer T, Petru E, Niederkorn A, Arzberger EJ, Richtig E.

Dermatology. 2014;229(4):288-92. doi: 10.1159/000365391. Epub 2014 Nov 27. Review.

PMID:
25472626
28.

MiR-96-5p influences cellular growth and is associated with poor survival in colorectal cancer patients.

Ress AL, Stiegelbauer V, Winter E, Schwarzenbacher D, Kiesslich T, Lax S, Jahn S, Deutsch A, Bauernhofer T, Ling H, Samonigg H, Gerger A, Hoefler G, Pichler M.

Mol Carcinog. 2015 Nov;54(11):1442-50. doi: 10.1002/mc.22218. Epub 2014 Sep 25.

PMID:
25256312
29.

Evaluation of the physical activity biography: sport and transport.

Rogen S, Hofmann P, Bauernhofer T, Müller W.

J Sports Sci Med. 2014 May 1;13(2):338-48. eCollection 2014 May.

30.

Changes in colorectal carcinoma genomes under anti-EGFR therapy identified by whole-genome plasma DNA sequencing.

Mohan S, Heitzer E, Ulz P, Lafer I, Lax S, Auer M, Pichler M, Gerger A, Eisner F, Hoefler G, Bauernhofer T, Geigl JB, Speicher MR.

PLoS Genet. 2014 Mar 27;10(3):e1004271. doi: 10.1371/journal.pgen.1004271. eCollection 2014 Mar.

31.

Sorafenib in advanced, heavily pretreated patients with soft tissue sarcomas.

Brämswig K, Ploner F, Martel A, Bauernhofer T, Hilbe W, Kühr T, Leitgeb C, Mlineritsch B, Petzer A, Seebacher V, Stöger H, Girschikofsky M, Hochreiner G, Ressler S, Romeder F, Wöll E, Brodowicz T.

Anticancer Drugs. 2014 Aug;25(7):848-53. doi: 10.1097/CAD.0000000000000108.

PMID:
24667659
32.

Loss of the putative tumor suppressor protein spinophilin is associated with poor prognosis in head and neck cancer.

Aigelsreiter AM, Aigelsreiter A, Wehrschuetz M, Ress AL, Koller K, Salzwimmer M, Gerger A, Schauer S, Bauernhofer T, Pichler M.

Hum Pathol. 2014 Apr;45(4):683-90. doi: 10.1016/j.humpath.2013.11.014. Epub 2013 Dec 2.

PMID:
24565202
33.

The PAM50 risk-of-recurrence score predicts risk for late distant recurrence after endocrine therapy in postmenopausal women with endocrine-responsive early breast cancer.

Filipits M, Nielsen TO, Rudas M, Greil R, Stöger H, Jakesz R, Bago-Horvath Z, Dietze O, Regitnig P, Gruber-Rossipal C, Müller-Holzner E, Singer CF, Mlineritsch B, Dubsky P, Bauernhofer T, Hubalek M, Knauer M, Trapl H, Fesl C, Schaper C, Ferree S, Liu S, Cowens JW, Gnant M; Austrian Breast and Colorectal Cancer Study Group.

Clin Cancer Res. 2014 Mar 1;20(5):1298-305. doi: 10.1158/1078-0432.CCR-13-1845. Epub 2014 Feb 11.

34.

MiR-200a regulates epithelial to mesenchymal transition-related gene expression and determines prognosis in colorectal cancer patients.

Pichler M, Ress AL, Winter E, Stiegelbauer V, Karbiener M, Schwarzenbacher D, Scheideler M, Ivan C, Jahn SW, Kiesslich T, Gerger A, Bauernhofer T, Calin GA, Hoefler G.

Br J Cancer. 2014 Mar 18;110(6):1614-21. doi: 10.1038/bjc.2014.51. Epub 2014 Feb 6.

35.

Three Metachronous Osteosarcomas within 22 Years without Pulmonary Metastases: A Case Report and Review of the Literature.

Pirker-Frühauf UM, Friesenbichler J, Rabitsch K, Liegl-Atzwanger B, Bauernhofer T, Windhager R, Leithner A.

Case Rep Orthop. 2013;2013:197287. doi: 10.1155/2013/197287. Epub 2013 Dec 25.

36.

miR-181a is associated with poor clinical outcome in patients with colorectal cancer treated with EGFR inhibitor.

Pichler M, Winter E, Ress AL, Bauernhofer T, Gerger A, Kiesslich T, Lax S, Samonigg H, Hoefler G.

J Clin Pathol. 2014 Mar;67(3):198-203. doi: 10.1136/jclinpath-2013-201904. Epub 2013 Oct 4.

PMID:
24098024
37.

The predictive value of serum soluble E-cadherin levels in breast cancer patients undergoing preoperative systemic chemotherapy.

Hofmann G, Balic M, Dandachi N, Resel M, Schippinger W, Regitnig P, Samonigg H, Bauernhofer T.

Clin Biochem. 2013 Oct;46(15):1585-9. doi: 10.1016/j.clinbiochem.2013.06.010. Epub 2013 Jun 18.

PMID:
23792261
38.

Complex tumor genomes inferred from single circulating tumor cells by array-CGH and next-generation sequencing.

Heitzer E, Auer M, Gasch C, Pichler M, Ulz P, Hoffmann EM, Lax S, Waldispuehl-Geigl J, Mauermann O, Lackner C, Höfler G, Eisner F, Sill H, Samonigg H, Pantel K, Riethdorf S, Bauernhofer T, Geigl JB, Speicher MR.

Cancer Res. 2013 May 15;73(10):2965-75. doi: 10.1158/0008-5472.CAN-12-4140. Epub 2013 Mar 7.

39.

Safety and efficacy of neoadjuvant FOLFIRINOX treatment in a series of patients with borderline resectable pancreatic ductal adenocarcinoma.

Tinchon C, Hubmann E, Pichler A, Keil F, Pichler M, Rabl H, Uggowitzer M, Jilek K, Leitner G, Bauernhofer T.

Acta Oncol. 2013 Aug;52(6):1231-3. doi: 10.3109/0284186X.2013.771821. Epub 2013 Feb 27. No abstract available.

PMID:
23445338
40.

Establishment of tumor-specific copy number alterations from plasma DNA of patients with cancer.

Heitzer E, Auer M, Hoffmann EM, Pichler M, Gasch C, Ulz P, Lax S, Waldispuehl-Geigl J, Mauermann O, Mohan S, Pristauz G, Lackner C, Höfler G, Eisner F, Petru E, Sill H, Samonigg H, Pantel K, Riethdorf S, Bauernhofer T, Geigl JB, Speicher MR.

Int J Cancer. 2013 Jul 15;133(2):346-56. doi: 10.1002/ijc.28030. Epub 2013 Feb 13.

41.

Heterogeneity of epidermal growth factor receptor status and mutations of KRAS/PIK3CA in circulating tumor cells of patients with colorectal cancer.

Gasch C, Bauernhofer T, Pichler M, Langer-Freitag S, Reeh M, Seifert AM, Mauermann O, Izbicki JR, Pantel K, Riethdorf S.

Clin Chem. 2013 Jan;59(1):252-60. doi: 10.1373/clinchem.2012.188557. Epub 2012 Nov 7.

42.

The ethics of space, design and color in an oncology ward.

Andritsch E, Stöger H, Bauernhofer T, Andritsch H, Kasparek AK, Schaberl-Moser R, Ploner F, Samonigg H.

Palliat Support Care. 2013 Jun;11(3):215-21. doi: 10.1017/S1478951512000077. Epub 2012 Aug 10.

PMID:
22883931
43.

[Therapy of castration-resistant prostate cancer].

Rauchenwald M, Bauernhofer T, De Santis M, Füreder T, Höltl W, Kramer G, Krause S, Loidl W, Oismüller R, Reissigl A, Schmeller N, Stackl W, Stoiber F, Krainer M.

Wien Klin Wochenschr. 2012 Aug;124(15-16):538-51. doi: 10.1007/s00508-012-0206-1. Epub 2012 Jul 20. German.

PMID:
22815001
44.

Sunitinib causes dose-dependent negative functional effects on myocardium and cardiomyocytes.

Rainer PP, Doleschal B, Kirk JA, Sivakumaran V, Saad Z, Groschner K, Maechler H, Hoefler G, Bauernhofer T, Samonigg H, Hutterer G, Kass DA, Pieske B, von Lewinski D, Pichler M.

BJU Int. 2012 Nov;110(10):1455-62. doi: 10.1111/j.1464-410X.2012.11134.x. Epub 2012 Apr 17.

45.

NEMO expression in human hepatocellular carcinoma and its association with clinical outcome.

Aigelsreiter A, Haybaeck J, Schauer S, Kiesslich T, Bettermann K, Griessbacher A, Stojakovic T, Bauernhofer T, Samonigg H, Kornprat P, Lackner C, Pichler M.

Hum Pathol. 2012 Jul;43(7):1012-9. doi: 10.1016/j.humpath.2011.08.009. Epub 2011 Dec 15.

PMID:
22176836
46.

Pancreatic adenocarcinoma with multiple eosinophilic extracellular deposits consistent with noncalcified psammoma bodies.

Schneider NI, Bauernhofer T, Schöllnast H, Ott A, Langner C.

Virchows Arch. 2011 Dec;459(6):623-5. doi: 10.1007/s00428-011-1159-x. Epub 2011 Oct 30. Review. No abstract available.

PMID:
22037658
47.

Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial.

Gnant M, Mlineritsch B, Stoeger H, Luschin-Ebengreuth G, Heck D, Menzel C, Jakesz R, Seifert M, Hubalek M, Pristauz G, Bauernhofer T, Eidtmann H, Eiermann W, Steger G, Kwasny W, Dubsky P, Hochreiner G, Forsthuber EP, Fesl C, Greil R; Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria.

Lancet Oncol. 2011 Jul;12(7):631-41. doi: 10.1016/S1470-2045(11)70122-X. Epub 2011 Jun 5.

PMID:
21641868
48.

Prolactin receptor is a negative prognostic factor in patients with squamous cell carcinoma of the head and neck.

Bauernhofer T, Pichler M, Wieckowski E, Stanson J, Aigelsreiter A, Griesbacher A, Groselj-Strele A, Linecker A, Samonigg H, Langner C, Whiteside TL.

Br J Cancer. 2011 May 10;104(10):1641-8. doi: 10.1038/bjc.2011.131. Epub 2011 Apr 19.

49.

Paraneoplastic limbic encephalitis in a patient with extragonadal choriocarcinoma--significance of onconeural antibodies.

Szkandera J, Ploner F, Bauernhofer T, Kasparek AK, Payer F, Balic M, Knechtel G, Gerger A, Gallè G, Samonigg H, Hofmann G.

Onkologie. 2010;33(8-9):452-4. doi: 10.1159/000317269. Epub 2010 Jul 6.

PMID:
20838061
50.

Genomic index of sensitivity to endocrine therapy for breast cancer.

Symmans WF, Hatzis C, Sotiriou C, Andre F, Peintinger F, Regitnig P, Daxenbichler G, Desmedt C, Domont J, Marth C, Delaloge S, Bauernhofer T, Valero V, Booser DJ, Hortobagyi GN, Pusztai L.

J Clin Oncol. 2010 Sep 20;28(27):4111-9. doi: 10.1200/JCO.2010.28.4273. Epub 2010 Aug 9.

Supplemental Content

Loading ...
Support Center